Doximity (NASDAQ:DOCSGet Rating) and GEMALTO NV/S (OTCMKTS:GTOMYGet Rating) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Analyst Ratings

This is a breakdown of current recommendations for Doximity and GEMALTO NV/S, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Doximity 3 3 7 0 2.31
GEMALTO NV/S 0 0 0 0 N/A

Doximity presently has a consensus target price of $40.50, suggesting a potential upside of 36.32%. Given Doximity’s higher probable upside, analysts clearly believe Doximity is more favorable than GEMALTO NV/S.

Institutional & Insider Ownership

52.5% of Doximity shares are held by institutional investors. 45.2% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Doximity has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, GEMALTO NV/S has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500.


This table compares Doximity and GEMALTO NV/S’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Doximity 29.59% 13.64% 11.83%

Earnings and Valuation

This table compares Doximity and GEMALTO NV/S’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Doximity $343.55 million 16.74 $154.78 million $0.55 54.02
GEMALTO NV/S $3.51 billion 1.45 $72.13 million N/A N/A

Doximity has higher earnings, but lower revenue than GEMALTO NV/S.


Doximity beats GEMALTO NV/S on 10 of the 11 factors compared between the two stocks.

About Doximity

(Get Rating)

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.


(Get Rating)

Gemalto N.V. provides digital security products and services worldwide. The company operates through two segments, Identity, IoT & Cybersecurity; and Smartcards & Issuance. It designs security solutions to governments, industrial companies, and enterprises; and ePassports, border and visa management, biometrics, ID and health cards, voter and vehicle registration, drivers' licenses, and eGovernment support services. The company also offers machine-to-machine, and Internet of Things solutions and services; encrypting data, securing identities, and managing access services; and software licensing solutions. In addition, it provides smart card products and solutions to financial institutions, retail, transport, and mobile network operators; and secures digital banking and payment apps and services, as well as protects company and customer data through encryption. Further, the company offers ID verification solutions, mobile and Assurance Hub technologies solutions, trusted services hub services. Additionally, it licenses its intellectual property and provides security and other technology advisory services. The company was formerly known as Axalto Holding N.V. and changed its name to Gemalto N.V. in June 2006. Gemalto N.V. was incorporated in 2002 and is headquartered in Amsterdam, the Netherlands. As of April 15, 2019, Gemalto N.V. operates as a subsidiary of Thales S.A.

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with's FREE daily email newsletter.